Ser1121
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.0.1
Powered by Cell Signaling Technology
Home > Phosphorylation Site Page: > Ser1121  -  ATP7B (human)

Site Information
AHSERPLsAPASHLN   SwissProt Entrez-Gene
Blast this site against: NCBI  SwissProt  PDB 
Site Group ID: 11267007

In vivo Characterization
Methods used to characterize site in vivo:
[32P] ATP in vitro ( 1 ) , mass spectrometry ( 2 ) , mass spectrometry (in vitro) ( 2 ) , mutation of modification site ( 1 ) , western blotting ( 1 )
Disease tissue studied:
hepatocellular carcinoma ( 1 )
Relevant cell line - cell type - tissue:
COS (fibroblast) ( 1 , 2 ) , Hep-G2/C3A (hepatic) ( 1 )

Upstream Regulation
Kinases, in vitro:
PRKD1 (human) ( 1 )
Treatments:
CID755673 ( 1 ) , copper ( 2 ) , phorbol_ester ( 1 )

Downstream Regulation
Effects of modification on ATP7B:
intracellular localization ( 1 ) , protein stabilization ( 1 )

References 

1

Pilankatta R, Lewis D, Inesi G (2011) Involvement of protein kinase D in expression and trafficking of ATP7B (copper ATPase). J Biol Chem 286, 7389-96
21189263   Curated Info

2

Pilankatta R, Lewis D, Adams CM, Inesi G (2009) High yield heterologous expression of wild-type and mutant Cu+-ATPase (ATP7B, Wilson disease protein) for functional characterization of catalytic activity and serine residues undergoing copper-dependent phosphorylation. J Biol Chem 284, 21307-16
19520855   Curated Info

Developed with grants from  NIH Logo and literature mining with Linguamatics  I2E Logo Creative Commons License PhosphoSite, created by Cell Signaling Technology is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 3.0 Unported License.

©2003-2019 Cell Signaling Technology, Inc.